Loading…
Asarfi Hospital (BSE 543943)₹178.75−3.38%Hospital
In the Jun 2026 quarter (consolidated), Asarfi Hospital reported sales of ₹47.72 Cr, up 33.2% from Jun 2025, and net profit of ₹4.26 Cr, up 37.0% year on year. For the year to Mar 2026, sales were ₹175 Cr and net profit ₹16.96 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 20.10 | 24.13 | 22.98 | 30.98 | 33.02 | 35.24 | 35.82 | 45.04 | 46.25 | 45.37 | 47.72 |
| Expenses | 16.07 | 20.15 | 18.20 | 24.16 | 26.01 | 28.88 | 28.77 | 36.12 | 36.10 | 37.61 | 38.17 |
| Operating Profit | 4.03 | 3.95 | 4.78 | 6.78 | 6.98 | 6.31 | 7.02 | 8.91 | 10.14 | 7.76 | 9.48 |
| OPM % | 20.0% | 16.4% | 20.8% | 21.9% | 21.2% | 17.9% | 19.6% | 19.8% | 21.9% | 17.1% | 19.9% |
| Other Income | 1.21 | −0.42 | 0.69 | 1.14 | 0.90 | 3.62 | 1.43 | 0.77 | 1.49 | 0.65 | 0.58 |
| Interest | 0.59 | 0.75 | 0.79 | 0.75 | 1.17 | 1.34 | 1.21 | 1.06 | 1.24 | 0.70 | 1.16 |
| Depreciation | 3.26 | 3.50 | 3.19 | 3.20 | 3.06 | 3.24 | 2.98 | 2.90 | 2.89 | 2.77 | 3.16 |
| Profit before tax | 1.37 | −0.73 | 1.47 | 3.95 | 3.63 | 5.31 | 4.21 | 5.66 | 7.46 | 4.91 | 5.71 |
| Tax % | 102.9% | −70.9% | 0.0% | 27.4% | 25.6% | 32.2% | 25.7% | 25.6% | 27.2% | 20.1% | 25.2% |
| Net Profit | −0.04 | −0.20 | 1.44 | 2.84 | 2.67 | 3.58 | 3.11 | 4.19 | 5.41 | 3.91 | 4.26 |
| EPS (Rs) | −0.04 | −0.12 | 0.75 | 1.46 | 1.37 | 1.83 | 1.60 | 2.14 | 2.76 | 2.00 | 2.18 |
| Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|
| Sales | 81.31 | 116 | 175 | 184 |
| Expenses | 65.16 | 93.24 | 138 | 148 |
| Operating Profit | 16.06 | 24.08 | 35.12 | 36.29 |
| OPM % | 20.0% | 20.0% | 20.0% | 19.7% |
| Other Income | 2.01 | 8.01 | 3.01 | 3.49 |
| Interest | 2.99 | 3.99 | 3.99 | 4.16 |
| Depreciation | 9.01 | 12.99 | 12.01 | 11.72 |
| Profit before tax | 6.01 | 14.02 | 22.03 | 23.74 |
| Tax % | 32.9% | 25.9% | 24.9% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | — |
| Net Profit | 3.99 | 10.98 | 16.96 | 17.77 |
| EPS (Rs) | 2.12 | 5.40 | 8.50 | 9.08 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | — |
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Equity Capital | 20.07 | 20.06 | 20.07 |
| Reserves | 50.93 | 61.01 | 77.99 |
| Borrowings | 31.87 | 48.81 | 57.77 |
| Other Liabilities | 52.01 | 34.05 | 38.05 |
| Total Liabilities | 154 | 164 | 193 |
| Fixed Assets | 93.84 | 102 | 108 |
| CWIP | 0.00 | 1.99 | 1.99 |
| Investments | 0.00 | 0.00 | 0.00 |
| Other Assets | 60.04 | 60.09 | 83.07 |
| Inventories | 1.99 | 1.99 | 2.99 |
| Trade receivables | 23.95 | 39.90 | 53.87 |
| Cash & equivalents | 0.99 | 0.99 | 12.95 |
| Total Assets | 154 | 164 | 193 |
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Cash from operating activity | 25.98 | −3.99 | 17.97 |
| Cash from investing activity | −63.23 | −7.02 | −18.06 |
| Cash from financing activity | 35.90 | 12.95 | 4.98 |
| Net cash flow | −0.99 | 0.99 | 4.99 |
| Capex | 45.93 | 9.82 | 18.07 |
| Free cash flow | −19.94 | −14.97 | 0.00 |
| CFO / OP % | 163.0% | −5.0% | 68.1% |
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Debtor days | 109 | 125 | 114 |
| Inventory days | 32 | 30 | 30 |
| Days payable | 448 | 172 | 157 |
| Cash conversion cycle | −305 | −16 | −12 |
| Working capital days | 4 | 51 | 20 |
| ROCE % | — | 16.0% | 19.0% |
For the Jun 2026 quarter, Asarfi Hospital reported sales of ₹47.72 Cr, up 33.2% year on year and net profit of ₹4.26 Cr, up 37.0% year on year. The operating margin was 19.9%.
Asarfi Hospital's sales for the year to Mar 2026 were ₹175 Cr; over the last twelve months they were ₹184 Cr.
Net profit for the year to Mar 2026 was ₹16.96 Cr, and ₹17.77 Cr over the last twelve months. Earnings per share over the same trailing period were ₹9.08.
Asarfi Hospital reported borrowings of ₹57.77 Cr at Mar 2026, against cash and equivalents of ₹12.95 Cr.
Cash from operations was ₹17.97 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹0 Cr.